Charles Schwab’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Charles Schwab’s Portfolio AXLA Stock Details AXLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-730	Closed	-$3.98K	–	3673
2023 Q2	$3.98K	Hold	730	–	–	﹤0.01%	3606
2023 Q1	$8.76K	Hold	730	–	–	﹤0.01%	3541
2022 Q4	$5.98K	Hold	730	–	–	﹤0.01%	3543
2022 Q3	$32K	Hold	730	–	–	﹤0.01%	3419
2022 Q2	$38K	Buy	+730	New	+$35.9K	﹤0.01%	3431
2021 Q3	–	Sell	-412	Closed	-$42K	–	3559
2021 Q2	$42K	Sell	412 -833	-67%	-$82.6K	﹤0.01%	3394
2021 Q1	$149K	Sell	1,245 -419	-25%	-$59.1K	﹤0.01%	3349
2020 Q4	$216K	Hold	1,664	–	–	﹤0.01%	3248
2020 Q3	$193K	Buy	1,664 +416	+33%	+$51.3K	﹤0.01%	3186
2020 Q2	$173K	Buy	1,248 +568	+84%	+$69.5K	﹤0.01%	3191
2020 Q1	$59K	Hold	680	–	–	﹤0.01%	3143
2019 Q4	$69K	Buy	+680	New	+$74.7K	﹤0.01%	3115

Other funds holding AXLA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab's AXLA Position: Q3 2023 in Review

Charles Schwab sold out of Axcella Health Inc. Common Stock (AXLA) in Q3 2023, closing a stake of 730 shares — an estimated $3.98K sold.

Charles Schwab first reported a position in AXLA in Q4 2019 and held it in 12 quarters. The position peaked at $216K in Q4 2020. 15 funds tracked by Wall St. Rank hold AXLA as of Q3 2023.

Charles Schwab reported no remaining Axcella Health Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Charles Schwab sold 730 Axcella Health Inc. Common Stock shares in Q3 2023, an estimated $3.98K.
Charles Schwab first reported a position in Axcella Health Inc. Common Stock in Q4 2019 and held it in 12 quarters.
Charles Schwab's Axcella Health Inc. Common Stock position peaked at $216K in Q4 2020.
15 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q3 2023.

Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.